Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #18,401 to #18,450.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Anti-LKM antibody (1 revision)
  2. Anti-NMDA receptor encephalitis case study one (1 revision)
  3. Anti-NMDA receptor encephalitis cost-effectiveness of therapy (1 revision)
  4. Anti-NMDA receptor encephalitis echocardiography or ultrasound (1 revision)
  5. Anti-NMDA receptor encephalitis electrocardiography (1 revision)
  6. Anti-NMDA receptor encephalitis future or investigational therapies (1 revision)
  7. Anti-Narcotics Force (ANF) (1 revision)
  8. Anti-aging (1 revision)
  9. Anti-cardiolipin antibodies (1 revision)
  10. Anti-centromere antibodies (1 revision)
  11. Anti-inflammatory (patient information) (1 revision)
  12. Anti-lymphocyte globulin (1 revision)
  13. Anti-mitochondrial antibody (1 revision)
  14. Anti-müllerian hormone (1 revision)
  15. Anti-nuclear antibody (1 revision)
  16. Anti-obesity medication (1 revision)
  17. Anti-suicide Blanket (1 revision)
  18. Anti-suicide smock (1 revision)
  19. Anti-topoisomerase antibodies (1 revision)
  20. Antiaggregants (1 revision)
  21. Antiaromaticity (1 revision)
  22. Antibody (1 revision)
  23. Antibody Dependent Cell Mediated Cytotoxicity (1 revision)
  24. Antibody dependent enhancement (1 revision)
  25. Anticipation (artificial intelligence) (1 revision)
  26. Anticipation (genetics) (1 revision)
  27. Anticoagulation therapy resident survival guide (1 revision)
  28. Antidepressants in Japan (1 revision)
  29. Antidiuretic (1 revision)
  30. Antidiuretic hormone (1 revision)
  31. Antidote (patient information) (1 revision)
  32. Antiferromagnetism (1 revision)
  33. Antiflatulent (1 revision)
  34. Antigen (1 revision)
  35. Antigen-presenting cell (1 revision)
  36. Antigenic drift (1 revision)
  37. Antigenic shift (1 revision)
  38. Antihemophilic Factor (Human) (patient information) (1 revision)
  39. Antihemophilic Factor (Recombinant) (patient information) (1 revision)
  40. Antimetabolite (1 revision)
  41. Antimonial (1 revision)
  42. Antimonial cup (1 revision)
  43. Antimony (1 revision)
  44. Antimony trifluoride (1 revision)
  45. Antimony triiodide (1 revision)
  46. Antineutrino (1 revision)
  47. Antioxidant (1 revision)
  48. Antiparasitic (1 revision)
  49. Antiphospholipid syndrome case study one (1 revision)
  50. Antipokhmelin (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"